A

Researcher Profile

Amit M Oza

7

Publications

2,603

Citations

10

Co-Authors

4

Active Years

Publications

Journal Article The Lancet Oncology Apr 01, 2022

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial

Rebecca Kristeleit · Alla Lisyanskaya · Alexander Fedenko · Mikhail Dvorkin +21 more

10.1016/s1470-2045(22)00122-x 137 citations

Open Access Journal Article International Journal of Gynecological Cancer Jul 01, 2021

Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3

Andrew R Clamp · Domenica Lorusso · Amit M Oza · Carol Aghajanian +19 more

10.1136/ijgc-2020-002240 13 citations

Journal Article The Lancet Oncology Jul 01, 2021

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Eric Pujade-Lauraine · Keiichi Fujiwara · Jonathan A Ledermann · Amit M Oza +17 more

10.1016/s1470-2045(21)00216-3 360 citations

Open Access Journal Article The Lancet Oncology May 01, 2021

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda · Anne Floquet · Jonathan A Ledermann · Rebecca Asher +107 more

10.1016/s1470-2045(21)00073-5 361 citations

Journal Article The Lancet Mar 01, 2019

Epithelial ovarian cancer

Stephanie Lheureux · Charlie Gourley · Ignace Vergote · Amit M Oza

10.1016/s0140-6736(18)32552-2 1,513 citations

Open Access Journal Article International Journal of Gynecological Cancer Feb 01, 2019

TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Victoria Mandilaras · Swati Garg · Michael Cabanero · Qian Tan +14 more

10.1136/ijgc-2018-000087 37 citations

Journal Article The Lancet Oncology Jan 01, 2015

Outcomes and endpoints in trials of cancer treatment: the past, present, and future

Michelle K Wilson · Katherine Karakasis · Amit M Oza

10.1016/s1470-2045(14)70375-4 182 citations

Publication Timeline

2022

1

2021

3

2019

2

2015

1

Frequent Co-Authors

Nicoletta Colombo

Jonathan A Ledermann

Susana Banerjee

Giovanni Scambia

Katherine Karakasis

Alexandra Leary

Alla Lisyanskaya

Domenica Lorusso

Rebecca Kristeleit